Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

DIPNECH

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | Mar 26, 2026

What is DIPNECH?

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia, commonly known as DIPNECH, is a rare lung condition characterised by abnormal overgrowth of neuroendocrine cells within the airways. It is considered a pre-malignant or early neoplastic condition that can progress to neuroendocrine tumours (NETs) of the lung.

It primarily affects middle-aged women who are non-smokers. The condition involves widespread small nodules in the lungs caused by proliferation of neuroendocrine cells.

Over time, some of these lesions may develop into carcinoid tumours, which are a type of lung neuroendocrine tumour.

Incidence

DIPNECH is rare and likely underdiagnosed because its symptoms mimic asthma. It is more commonly reported in women and usually identified in middle age.

Symptoms

Patients typically present with chronic cough and shortness of breath. Wheezing is common and may not respond well to asthma treatment.

Because the condition progresses slowly, symptoms may persist for years before correct diagnosis. In cases where neuroendocrine tumours develop, additional lung nodules may appear on imaging.

Diagnosis

High-resolution CT scan of the chest often shows multiple small lung nodules and air trapping. Pulmonary function tests may show obstructive patterns.

Definitive diagnosis requires lung biopsy. Microscopic examination shows diffuse proliferation of neuroendocrine cells in the bronchial walls. If tumourlets or carcinoid tumours are present, they are identified during histological analysis.

Treatment

Management depends on severity. In mild cases, monitoring and symptom control may be sufficient. Bronchodilators and inhaled steroids are sometimes used for symptom relief.

If neuroendocrine tumours develop, surgical removal of localised tumours may be performed. In progressive cases, somatostatin analogues may help control symptoms and tumour growth.

Prognosis

DIPNECH generally progresses slowly. Many patients live for years with stable disease. However, in some individuals, progression to carcinoid tumours can occur. Regular imaging and follow-up are important to detect progression early.


You can help us with your donation:

Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:

Donations — Without a Ribbon is grateful when we receive every donation. Giving to Without a Ribbon helps us to provide ongoing support, organise the annual gathering and subsidise the costs of our Warriors attending these conferences.
Sponsorship — If you wish to sponsor our charity, please contact us using this form.
Volunteering — We are always looking for volunteers to help with different aspects of running our charity. So, if you are looking for volunteer work, please feel free to contact us.

Share:

PreviousOur New Resource Page for Malignant PEComa

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter